WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007092000) INHIBITORS OF HCV REPLICATION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/092000    International Application No.:    PCT/US2006/004156
Publication Date: 16.08.2007 International Filing Date: 06.02.2006
IPC:
C07D 487/04 (2006.01), C07D 471/04 (2006.01), C07D 491/14 (2006.01), C07D 403/04 (2006.01), A61K 31/55 (2006.01), A61P 31/14 (2006.01)
Applicants: BRISTOL-MYERS SQUIBB COMPANY [US/US]; Route 206 And Province Line Road, Princeton, New Jersey 08543-4000 (US) (For All Designated States Except US).
HUDYMA, Thomas, W. [US/US]; (US) (For US Only).
ZHENG, Xiaofan [CN/US]; (US) (For US Only).
HE, Feng [CN/US]; (US) (For US Only).
DING, Min [US/US]; (US) (For US Only).
BERGSTROM, Carl, P. [US/US]; (US) (For US Only).
HEWAWASAM, Piyasena [US/US]; (US) (For US Only).
MARTIN, Scott, W. [US/US]; (US) (For US Only).
GENTLES, Robert, G. [GB/US]; (US) (For US Only)
Inventors: HUDYMA, Thomas, W.; (US).
ZHENG, Xiaofan; (US).
HE, Feng; (US).
DING, Min; (US).
BERGSTROM, Carl, P.; (US).
HEWAWASAM, Piyasena; (US).
MARTIN, Scott, W.; (US).
GENTLES, Robert, G.; (US)
Agent: EPPERSON, James; Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000 (US)
Priority Data:
Title (EN) INHIBITORS OF HCV REPLICATION
(FR) INHIBITEURS DE RÉPLICATION DU VHC
Abstract: front page image
(EN)Indole compounds of Formula I are described. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV. Different forms and compositions comprising the compounds are also described as well as methods of preparing the compounds. (I)
(FR)L'invention concerne des composés indole de Formule I. Les composés ont une activité contre le virus de l'hépatite C (VHC) et sont utiles pour traiter les individus infectés par le VHC. L'invention concerne également différentes formes et compositions qui comprennent les composés ainsi que des méthodes de préparation des composés. (I)
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)